| 1 |
Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects |
|
|
| Chinyere Aloke, Ikechukwu Achilonu |
|
| Microbial Pathogenesis. 2022; : 105963 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
The future of recombinant host defense peptides |
|
|
| Ramon Roca-Pinilla, Leszek Lisowski, Anna Arís, Elena Garcia-Fruitós |
|
| Microbial Cell Factories. 2022; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Targeted Antimicrobial Agents as Potential Tools for Modulating the Gut Microbiome |
|
|
| Shuli Chou, Shiqing Zhang, Huating Guo, Yung-fu Chang, Wenjing Zhao, Xiangyu Mou |
|
| Frontiers in Microbiology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides |
|
|
| Denise Bellotti, Maurizio Remelli |
|
| Molecules. 2022; 27(14): 4584 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs) |
|
|
| Gabrielle S. Dijksteel, Magda M. W. Ulrich, Esther Middelkoop, Bouke K. H. L. Boekema |
|
| Frontiers in Microbiology. 2021; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Antimicrobial Peptides: A Potent Alternative to Antibiotics |
|
|
| Mariam Rima, Mohamad Rima, Ziad Fajloun, Jean-Marc Sabatier, Burkhard Bechinger, Thierry Naas |
|
| Antibiotics. 2021; 10(9): 1095 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal? |
|
|
| Adriana Barreto-Santamaría, Gabriela Arévalo-Pinzón, Manuel A. Patarroyo, Manuel E. Patarroyo |
|
| Antibiotics. 2021; 10(12): 1499 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Cationic Antimicrobial Peptides Are Leading the Way to Combat Oropathogenic Infections |
|
|
| Bruce Lin, Rong Li, Thomas N.G. Handley, John D. Wade, Wenyi Li, Neil M. O’Brien-Simpson |
|
| ACS Infectious Diseases. 2021; 7(11): 2959 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design |
|
|
| Angel León-Buitimea, Cesar R. Garza-Cárdenas, Javier A. Garza-Cervantes, Jordy A. Lerma-Escalera, Jose R. Morones-Ramírez |
|
| Frontiers in Microbiology. 2020; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
